Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
30-Mar-2026 | 426.1 | 436.7 | 414.2 | 434 | 17,065 | 10,04,30,298.3 | 1,02,642 |
01-Apr-2026 | 444 | 444 | 420.3 | 424.25 | 16,600 | 10,71,74,643.05 | 99,207 |
02-Apr-2026 | 415.25 | 430.9 | 412.25 | 421.75 | 17,559 | 23,70,51,818.5 | 3,93,955 |
06-Apr-2026 | 433 | 441.8 | 422 | 430.75 | 32,559 | 56,79,65,714.9 | 4,18,356 |
07-Apr-2026 | 425.05 | 438.25 | 425.05 | 434.4 | 12,398 | 7,57,26,556.7 | 68,746 |
08-Apr-2026 | 444 | 460.85 | 429.15 | 456 | 17,540 | 19,05,79,421.85 | 2,40,147 |
09-Apr-2026 | 455.9 | 459.7 | 447.5 | 456.9 | 9,468 | 3,65,88,804.45 | 28,078 |
10-Apr-2026 | 458.9 | 471.8 | 455.7 | 468.1 | 10,076 | 7,12,45,203.5 | 83,804 |
13-Apr-2026 | 452.1 | 471.8 | 452.1 | 462.35 | 11,546 | 6,58,51,867.85 | 73,816 |
15-Apr-2026 | 469 | 483 | 460.15 | 477.55 | 13,237 | 11,22,05,236.85 | 95,644 |
16-Apr-2026 | 482.35 | 484.5 | 471.2 | 472.25 | 4,124 | 3,77,59,423.65 | 43,720 |
17-Apr-2026 | 473.45 | 473.95 | 465.15 | 471.7 | 7,417 | 5,07,63,413.75 | 68,185 |
20-Apr-2026 | 471.7 | 477.5 | 464 | 475.4 | 7,607 | 5,21,61,101.15 | 60,029 |
21-Apr-2026 | 475 | 494.4 | 472.1 | 484.3 | 8,908 | 8,22,38,510 | 86,076 |
22-Apr-2026 | 482 | 487.2 | 473 | 476.65 | 4,443 | 2,56,42,365.7 | 28,559 |
23-Apr-2026 | 476 | 477.75 | 469.55 | 472.2 | 4,764 | 2,67,65,895.75 | 23,835 |
24-Apr-2026 | 470.8 | 477.95 | 463.25 | 467.1 | 3,936 | 1,85,83,939.9 | 18,126 |
27-Apr-2026 | 467.1 | 480 | 463 | 476.5 | 8,595 | 5,23,33,673.4 | 52,476 |
Metropolis Healthcare said it plans to expand its genomic test portfolio to more than 500 advanced tests over the next two to three years
The deal includes a deferred payment of ₹1.7 crore, which will be disbursed as per the terms of the business transfer agreement, the company said in a regulatory filing.
The EBITDA margin fell to 18% in Q4 FY25 from 24.2% in Q4 FY24, reflecting a fall in operational efficiency or profitability.
The EBITDA margin was stable at 22.3% and did not change much from the year-ago period.
This is a 100% stake purchase that will be funded through 55% cash and 45% equity swap. It expects completion in 60 days, after shareholders give their nod.
Here are some of the stocks that may see significant price movement today: Tata Motors, Asian Paints, Divi’s Laboratories, etc.
Here are some of the stocks that may see significant price movement today: Titan Company, HDFC Bank, IndusInd Bank, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
